Dalfampridine: is the seizure risk greater than previously thought?

Am J Phys Med Rehabil. 2013 Jul;92(7):635-6. doi: 10.1097/PHM.0b013e31826ed8ea.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • 4-Aminopyridine / adverse effects*
  • 4-Aminopyridine / therapeutic use
  • Donepezil
  • Follow-Up Studies
  • Humans
  • Indans / therapeutic use
  • Middle Aged
  • Multiple Sclerosis / diagnosis
  • Multiple Sclerosis / drug therapy*
  • Piperidines / therapeutic use
  • Potassium Channel Blockers / administration & dosage
  • Potassium Channel Blockers / adverse effects*
  • Risk Assessment
  • Seizures / chemically induced*
  • Seizures / physiopathology
  • Severity of Illness Index

Substances

  • Indans
  • Piperidines
  • Potassium Channel Blockers
  • Donepezil
  • 4-Aminopyridine